About BANZEL

Indication

BANZEL (rufinamide) is a prescription medication approved for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults.

Seizures associated with Lennox-Gastaut syndrome (LGS) are hard to control. BANZEL is prescribed only as an add-on to one or more anti-epileptic treatments already being taken.

Additional seizure control may be within reach

BANZEL, as an add-on therapy, is used to reduce seizures associated with Lennox-Gastaut syndrome (LGS) in children 1 year of age or older and adults.

 
A clinical study of patients with LGS (ages 4-30) showed that when BANZEL was added to their current therapy, BANZEL:
  • Reduced the frequency of tonic-atonic seizures (drop attacks)

    (reduction of 42.5% in the frequency of this type of seizure versus a increase of 1.4% in the placebo group)

  • Reduced the frequency of total seizures

    (reduction of 32.7% versus 11.7% for the placebo group)

  • Reduced the severity of seizures

    (more parents or guardians of the BANZEL patients reported improvements in seizure severity than those in the placebo group—53.4% versus 30.6%)

 

BANZEL has been associated with side effects such as sleepiness or feeling tired, difficulty with coordination, dizziness, and problems with walking or movement. BANZEL is not a benzodiazepine. Be sure to talk with your doctor for more information about the risks associated with BANZEL.

Know the medicines your loved one takes. Keep a list of them and show it to your doctor and pharmacist each time you get a new medicine. Include prescription and non-prescription medications, vitamins, and supplements. Remember, BANZEL is an add-on medicine. People with LGS experiencing inadequate seizure control may have BANZEL added to their existing therapy. With BANZEL, additional seizure control may be within reach.

Taking BANZEL with certain other medications can cause side effects or affect how well they work. Other medicines should not be started or stopped without talking to your healthcare provider.

Please see the important safety information below to learn more about risks associated with BANZEL.

 
 


  • BANZEL: A Video Series BANZEL: A Video Series

    BANZEL®: A Video Series

    See how families are taking on LGS, from symptoms and diagnosis to treatment.

    WATCH NOW

    BANZEL®: A Video Series

    See how families are taking on LGS, from symptoms and diagnosis to treatment.

  • BANZEL Connections Savings Card BANZEL Connections Savings Card

    BANZEL Connections & Savings Card

    Get exclusive information from LGS experts and savings on your prescriptions.

    SIGN UP NOW

    BANZEL Connections & Savings Card

    Get exclusive information from LGS experts and savings on your prescriptions.

  • FDA Approved FDA Approved

    An FDA-approved add-on medication for seizures associated with LGS in children as young as 1 year of age

    An FDA-approved add-on medication for seizures associated with LGS in children as young as 1 year of age

    LEARN MORE